{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:46:37Z","timestamp":1776746797072,"version":"3.51.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The objective of this study is to investigate the efficacy of megestrol acetate (MA) in treating cancer cachexia from multiple dimensions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective, non-randomized study, 97 patients with cancer cachexia were allocated to either a control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f33, regular diet) or an MA group (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f64, regular diet plus MA 320\u202fmg\/day) for 2 months. The primary endpoints were nutritional indices, including weight, BMI, total skeletal muscle mass, and fat mass. Secondary endpoints included inflammatory markers (CRP, IL-6, TNF-\n                      <jats:italic>\u03b1<\/jats:italic>\n                      ), immune parameters (CD4\n                      <jats:sup>+<\/jats:sup>\n                      , CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells), cancer-related fatigue (assessed by the Cancer Fatigue Scale), and quality of life (QOL).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to baseline, the MA group exhibited significant improvements in body weight, BMI, fat mass, prealbumin (PA), albumin (ALB), and hemoglobin (Hb), coupled with a significant reduction in IL-6 levels and all domains of cancer-related fatigue (somatic, cognitive, affective, and total). Between-group analyses demonstrated that the MA group achieved significantly greater improvements in weight, BMI, fat mass, PA, ALB, and Hb. Skeletal muscle mass was maintained in the MA group, whereas the control group experienced a significant loss, resulting in a significant between-group difference. Furthermore, the MA group showed markedly greater reductions in all fatigue domain scores and a more substantial improvement in QOL. No significant between-group differences were observed for most inflammatory or immune markers. The intervention was well-tolerated with no reported drug-related adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MA significantly improves nutritional status and ameliorates cancer-related fatigue, thereby enhancing the quality of life in patients with cancer cachexia. Our findings provide robust evidence supporting the multi-dimensional benefits of MA in cachexia management, extending beyond mere weight gain to include muscle mass preservation and patient-centered symptom relief.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1780653","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:22:44Z","timestamp":1776745364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Megestrol acetate in the management of cancer cachexia: a prospective quasi-experimental study focusing on body composition and patient-reported outcomes"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoting","family":"Zhong","sequence":"first","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Gannan Medical University","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangcai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiling","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Gannan Medical University","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi \u201cFlagship\u201d Oncology Department of Synergy for Chinese and Western Medicine","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Provincial Unit for Clinical Key Oncology Specialty Development","place":["Ganzhou, Jiangxi, China"]},{"name":"Jiangxi Clinical Research Center for Cancer","place":["Ganzhou, Jiangxi, China"]},{"name":"Department of Oncology, The First Affiliated Hospital, Jinan University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.critrevonc.2012.02.011","article-title":"Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients","volume":"84","author":"Trajkovic-Vidakovic","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.clnu.2016.12.003","article-title":"Association between cachexia, chemotherapy and outcomes in older cancer patients: a systematic review","volume":"36","author":"Caillet","year":"2017","journal-title":"Clin Nutr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.3390\/ijms22168491","article-title":"Cancer cachexia: its mechanism and clinical significance","volume":"22","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/cancers14092107","article-title":"Molecular mechanisms and current treatment options for cancer cachexia","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cancers"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/jcsm.12292","article-title":"Megestrol acetate for cachexia-anorexia syndrome. A systematic review: megestrol acetate for cachexia-anorexia syndrome","volume":"9","author":"Ruiz-Garc\u00eda","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer cachexia: beyond weight loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"JOP"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.clnu.2013.01.004","article-title":"A new look at an old drug for the treatment of cancer cachexia: megestrol acetate","volume":"32","author":"Argil\u00e9s","year":"2013","journal-title":"Clin Nutr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ygyno.2005.11.044","article-title":"Megestrol acetate induced hypoadrenalism with cushingoid phenotype in endometrial cancer","volume":"101","author":"Ozguroglu","year":"2006","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s005200050288","article-title":"Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer fatigue scale","volume":"8","author":"Okuyama","year":"2000","journal-title":"Support Care Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.21037\/atm-22-4809","article-title":"Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study","volume":"10","author":"Ma","year":"2022","journal-title":"Ann Transl Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/pbc.24828","article-title":"A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and\/or cancer therapy","volume":"61","author":"Cuvelier","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/nu9080829","article-title":"Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2017","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jcsm.12035","article-title":"A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy","volume":"7","author":"Toledo","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref16","first-page":"2216","article-title":"Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer","volume":"81","author":"Frost","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/jcsm.12116","article-title":"Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation","volume":"7","author":"Musolino","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00520-018-4047-y","article-title":"Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers","volume":"26","author":"Kouchaki","year":"2018","journal-title":"Support Care Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/nu12061543","article-title":"Pancreatic Cancer and Cachexia-metabolic mechanisms and novel insights","volume":"12","author":"Poulia","year":"2020","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1038\/s42255-024-01167-9","article-title":"Cancer cachexia: multilevel metabolic dysfunction","volume":"6","author":"Berriel Diaz","year":"2024","journal-title":"Nat Metab"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","article-title":"Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment","volume":"31","author":"Fabi","year":"2020","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1780653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:22:46Z","timestamp":1776745366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1780653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":26,"alternative-id":["10.3389\/fnut.2026.1780653"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1780653","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1780653"}}